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Objectives: To determine whether low platelet response to the P2Y12
receptor antagonist clopidogrel as assessed by VAsodilator Stimulated Phos-
phoprotein flow cytometry test (VASP- FCT) has the same deleterious clinical
impact in patients with or without chronic kidney disease (CKD) undergoing
percutaneous coronary intervention (PCI).
Background: Whilst both CKD and impaired platelet responsiveness to
clopidogrel are strong predictors of unfavourable outcome after PCI, the dele-
terious impact of their association is unknown. The platelet VASP-FCT assay
is specific of the P2Y12 ADP receptor-pathway. In this test, platelet activation
is expressed as Platelet Reactivity Index (PRI).
Methods: 440 unselected patients (CKD: 126 (eGFR<60 ml/min/1.73m2),
NoCKD: 314 eGFR>60 ml/min/1.73m2) undergoing urgent (n=336) or planned
(n=104) PCI were prospectively enrolled. In each sub-group, patients were
classified as low-responders (LR: PRI≥61%) and responders (R: PRI<61%) to
clopidogrel. The 61% threshold was previously defined as the optimal cut-off
value to predict cardiac death following PCI.
Results: At a mean follow-up of 9±2 months, cardiac death, probable and
possible stent thrombosis rates were higher in CKD patients. In this sub-group,
cardiac death, total stent thrombosis and MACE were dramatically increased
in LR patients, especially when treated with drug eluting stent (DES). Con-
versely, in NoCKD patients, LR was not associated with poorer cardiovascular
outcome. Multivariate analysis identified Killip class ≥ 3, DES implantation
and the interaction between LR and CKD (HR 11.96 [1.22-116.82]; p = 0.033)
as independent predictors of cardiac death. 
Conclusions: In CKD patients, cardiovascular mortality following PCI is
mainly related to impaired P2Y12 inhibition. 
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Purpose: Octogenarians with acute coronary syndrome (ACS) represent
both a challenge and a dilemma to the clinicians as they frequently present
with important co-morbidities. We sought to characterize octogenarian patients
admitted with an ACS.
Methods: A total of 1959 patients consecutively admitted with ACS were
reviewed. We compared patients of 80 years or more to the others in order to char-
acterize them beyond age. Independent predictors of six-month prognosis were
determined among octogenarian patients. The end point was six-month mortality.
Results: We compared the characteristics of 251 octogenarians (mean age, 84
± 3 years) with those of 1708 younger patients (mean age, 62 ± 12 years).
Octogenarians were more frequently women; they more often had arterial
hypertension and renal insufficiency (p <0.05). There were no differences
regarding ACS presentation but octogenarians presented more frequently with
Killip class higher than one at admission (p <0.05). Octogenarians were less
likely to be medicated with β-blocker (p <0.05). Although elderly patients less
often underwent coronariography, there were no differences regarding percu-
taneous revascularization. The ACS in octogenarians were more frequently
complicated with cardiogenic shock and mechanical complications, as well as
with major noncardiac conditions that strongly and negatively influenced the
six-month mortality. When considering only octogenarians, independent and
positive predictors of six-month mortality were cardiogenic shock, major non-
cardiac condition and lower nadir haemoglobin concentration while negative
predictors were β-blocker and angiotensin-converting enzyme inhibitor use
during in-hospital stay.
Conclusions: Octogenarians represented 10.8% of our ACS patients. These
elderly patients presented worse prognosis at six-months that appeared more
strongly linked to the occurrence of major cardiac and noncardiac complica-
tions that to the use of invasive strategy and coronary revascularization. 
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Background :Thrombus aspiration is applicable in a large majority of
patients with ST-segment elevation myocardial infarction (STEMI), and it
results in better reperfusion and clinical outcomes than conventional PCI.
However, some aspiration procedures remain none productive. Then, the aim
of the present study was to determine the baseline clinical and /or angio-
graphic characteristics of a none effective thrombectomy.
Methods : Consecutive patients who benefited from thrombus aspiration and
primary or rescue angioplasty, were included. The end point was effective or
none effective aspiration defined by the presence of atherothrombotic material
in the aspirate samples.
Results : Among the 180 patients included, material was collected in 155
patients (86 %). The baseline characteristics are presented in table 1. 
Table 1 – Baseline characteristics
In multivariate analysis, the ability to remove the clot is negatively influ-
enced by: a) age>70 years [OR(95%CI): 5.459 (1.943-15.339); p=0.001 b)
admission systolic blood pressure [OR(95%CI): 1.028 (1.010-1.048); p=0.003]
and c) no thrombus seen on the angiography [OR(95%CI): 0.220 (0.074-
0.651), p=0.006]
Thrombectomy Not effective Effective p
Men (%) 80 % 69 % NS
Age (years, mean ± SD) 70 ± 15 62 ± 14 < 0.05
Heart Rate (mean ± SD) 81 ± 23 74 ± 21 NS
Systolic Blood pressure 
(mm Hg, mean ± SD) 
150 ± 32 134 ± 27 <0.005
Delay symptoms-reperfusion 
(min, mean ± SD) 
504 ± 572 641 ± 1064 NS
Culprit lesion (%)
Left anterior artery
Circumflex artery
Right artery
 
48 %
8 %
36 %
 
35 %
9 %
52 %
 
NS
NS
NS
AHA classification
AHA A 
AHA B1
AHA B2
AHA C 
 
0 %
24 %
76 %
0 %
 
3 %
27 %
70 %
1 %
 
NS
NS 
NS
NS 
Visible thrombus (%) 28 % 61 % 0.005
Length (mm) 
< 10mm
10 – 20 mm
> 10 mm
 
0 %
48 %
52 %
 
3 %
47 %
50 %
 
NS
NS 
N 
Calcification (%) 60 % 37 % 0.048
